Aspergillus terreus and Aspergillus niger
Aspergillus terreus; Aspergillus niger
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
Environmental molds found in soil and decaying matter.
Infections
Onychomycosis (non-dermatophyte), otomycosis, wound infection; invasive aspergillosis in immunocompromised patients.
Signs and symptoms
Discolored, thickened nails; ear itching and discharge.
Antibiotic and antimicrobial resistance
A. terreus is intrinsically resistant to amphotericin B.
Treatment considerations
Depends on site; nail infection may need topical or systemic antifungals, and invasive disease needs voriconazole-class therapy with specialist input.

Sources
- CDC. Aspergillosis.
- IDSA. Aspergillosis guideline.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.